Cargando…

Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma

BACKGROUND: Nardostachys jatamansi DC is a Himalayan medicinal herb that has been described in various traditional systems of medicine for its use in cancer. In view of its traditional claims, and chemical constituents, antioxidant and anticancer activities were evaluated in breast carcinoma. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Shilpee, Chandrashekar, Kodangala Subraya, Pai, Karkala Sreedhara Ranganath, Setty, Manganahalli Manjunath, Devkar, Raviraj Anand, Reddy, Neetinkumar Dnyanoba, Shoja, Muhammed Haneefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364107/
https://www.ncbi.nlm.nih.gov/pubmed/25886964
http://dx.doi.org/10.1186/s12906-015-0563-1
_version_ 1782362026049273856
author Chaudhary, Shilpee
Chandrashekar, Kodangala Subraya
Pai, Karkala Sreedhara Ranganath
Setty, Manganahalli Manjunath
Devkar, Raviraj Anand
Reddy, Neetinkumar Dnyanoba
Shoja, Muhammed Haneefa
author_facet Chaudhary, Shilpee
Chandrashekar, Kodangala Subraya
Pai, Karkala Sreedhara Ranganath
Setty, Manganahalli Manjunath
Devkar, Raviraj Anand
Reddy, Neetinkumar Dnyanoba
Shoja, Muhammed Haneefa
author_sort Chaudhary, Shilpee
collection PubMed
description BACKGROUND: Nardostachys jatamansi DC is a Himalayan medicinal herb that has been described in various traditional systems of medicine for its use in cancer. In view of its traditional claims, and chemical constituents, antioxidant and anticancer activities were evaluated in breast carcinoma. METHODS: Petroleum ether (NJPE), methanol extract (NJM) and subsequent diethyl ether (NJDE), ethyl acetate (NJEA) and aqueous (NJAQ) fractions of roots and rhizomes of N. jatamansi were prepared. Total phenolic, flavonoid content, and antioxidant activities were determined using suitable methods. Antiproliferative activity was assessed in estrogen receptor (ER)-positive (MCF-7) and ER-negative breast carcinoma (MDA-MB-231) cells by MTT and SRB assay. Cell cycle analysis, Hoechst staining, and clonogenic assay were employed to determine the mode of antiproliferative and pro-apoptotic activity in MDA-MB-231 cells. RESULTS: NJM/fractions exhibited prominent antioxidant activity with significant correlation between phenolic content and ABTS (IC(50)) scavenging (R = −0.9680, P < 0.05), and total antioxidant capacity (R = 0.8396, P > 0.05). In MTT assay, NJM exhibited the highest antiproliferative activity (IC(50): 58.01 ± 6.13 and 23.83 ± 0.69 μg/mL in MCF-7 and MDA-MB-231 respectively). Among the fractions, NJPE and NJDE were found to be most potent in MCF-7 (IC(50): 60.59 ± 4.78 μg/mL) and MDA-MB-231 (IC(50): 25.04 ± 0.90 μg/mL) cells respectively. Statistical analyses revealed NJM and NJDE exhibited significantly higher (P < 0.05) cytotoxicity in MDA-MB-231 cells. Cell cycle analysis demonstrated that NJM, NJPE and NJEA caused G(2)/M arrest while NJDE caused G(0)/G(1) phase arrest in MDA-MB-231 cells. Further, NJM/fractions induced significant (P < 0.001) cell death by apoptosis characterized by apoptotic morphological changes in Hoechst staining and inhibited long-term proliferation (P < 0.001) of MDA-MB-231 cells in clonogenic assay. Lupeol and β-sitosterol were identified as anticancer principles in NJM/fractions by HPTLC. CONCLUSION: Our results suggest that NJM/fractions possess significant antiproliferative potential which is mediated through cell cycle perturbation and pro-apoptotic effects in MDA-MB-231 cells. Moreover, this study highlights the antioxidant potential of NJM/fractions which can be attributed to the presence of phenols. NJDE emerged as the most potent fraction and further mechanistic and phytochemical investigations are under way to identify the active principles.
format Online
Article
Text
id pubmed-4364107
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43641072015-03-19 Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma Chaudhary, Shilpee Chandrashekar, Kodangala Subraya Pai, Karkala Sreedhara Ranganath Setty, Manganahalli Manjunath Devkar, Raviraj Anand Reddy, Neetinkumar Dnyanoba Shoja, Muhammed Haneefa BMC Complement Altern Med Research Article BACKGROUND: Nardostachys jatamansi DC is a Himalayan medicinal herb that has been described in various traditional systems of medicine for its use in cancer. In view of its traditional claims, and chemical constituents, antioxidant and anticancer activities were evaluated in breast carcinoma. METHODS: Petroleum ether (NJPE), methanol extract (NJM) and subsequent diethyl ether (NJDE), ethyl acetate (NJEA) and aqueous (NJAQ) fractions of roots and rhizomes of N. jatamansi were prepared. Total phenolic, flavonoid content, and antioxidant activities were determined using suitable methods. Antiproliferative activity was assessed in estrogen receptor (ER)-positive (MCF-7) and ER-negative breast carcinoma (MDA-MB-231) cells by MTT and SRB assay. Cell cycle analysis, Hoechst staining, and clonogenic assay were employed to determine the mode of antiproliferative and pro-apoptotic activity in MDA-MB-231 cells. RESULTS: NJM/fractions exhibited prominent antioxidant activity with significant correlation between phenolic content and ABTS (IC(50)) scavenging (R = −0.9680, P < 0.05), and total antioxidant capacity (R = 0.8396, P > 0.05). In MTT assay, NJM exhibited the highest antiproliferative activity (IC(50): 58.01 ± 6.13 and 23.83 ± 0.69 μg/mL in MCF-7 and MDA-MB-231 respectively). Among the fractions, NJPE and NJDE were found to be most potent in MCF-7 (IC(50): 60.59 ± 4.78 μg/mL) and MDA-MB-231 (IC(50): 25.04 ± 0.90 μg/mL) cells respectively. Statistical analyses revealed NJM and NJDE exhibited significantly higher (P < 0.05) cytotoxicity in MDA-MB-231 cells. Cell cycle analysis demonstrated that NJM, NJPE and NJEA caused G(2)/M arrest while NJDE caused G(0)/G(1) phase arrest in MDA-MB-231 cells. Further, NJM/fractions induced significant (P < 0.001) cell death by apoptosis characterized by apoptotic morphological changes in Hoechst staining and inhibited long-term proliferation (P < 0.001) of MDA-MB-231 cells in clonogenic assay. Lupeol and β-sitosterol were identified as anticancer principles in NJM/fractions by HPTLC. CONCLUSION: Our results suggest that NJM/fractions possess significant antiproliferative potential which is mediated through cell cycle perturbation and pro-apoptotic effects in MDA-MB-231 cells. Moreover, this study highlights the antioxidant potential of NJM/fractions which can be attributed to the presence of phenols. NJDE emerged as the most potent fraction and further mechanistic and phytochemical investigations are under way to identify the active principles. BioMed Central 2015-03-10 /pmc/articles/PMC4364107/ /pubmed/25886964 http://dx.doi.org/10.1186/s12906-015-0563-1 Text en © Chaudhary et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chaudhary, Shilpee
Chandrashekar, Kodangala Subraya
Pai, Karkala Sreedhara Ranganath
Setty, Manganahalli Manjunath
Devkar, Raviraj Anand
Reddy, Neetinkumar Dnyanoba
Shoja, Muhammed Haneefa
Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title_full Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title_fullStr Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title_full_unstemmed Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title_short Evaluation of antioxidant and anticancer activity of extract and fractions of Nardostachys jatamansi DC in breast carcinoma
title_sort evaluation of antioxidant and anticancer activity of extract and fractions of nardostachys jatamansi dc in breast carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364107/
https://www.ncbi.nlm.nih.gov/pubmed/25886964
http://dx.doi.org/10.1186/s12906-015-0563-1
work_keys_str_mv AT chaudharyshilpee evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT chandrashekarkodangalasubraya evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT paikarkalasreedhararanganath evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT settymanganahallimanjunath evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT devkarravirajanand evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT reddyneetinkumardnyanoba evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma
AT shojamuhammedhaneefa evaluationofantioxidantandanticanceractivityofextractandfractionsofnardostachysjatamansidcinbreastcarcinoma